drugset
drugset / Trial / NCT01938599

Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis

NCT01938599 ↗

Phase 2 Completed 92 enrolled AmDerma
RandomizedParallel-groupTriple-blindTreatment

Summary

To compare the safety and efficacy profile of AM001 Cream and its vehicle in the treatment of plaque psoriasis.

Timeline

Start
2013-08
Primary completion
2014-05
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject AM001 Unknown 7.5 % —

Indications

erythematosquamous dermatosis psoriasis